Back | Next |
home / stock / nbio / nbio message board
Subject | By | Source | When |
---|---|---|---|
Looking forward to it | Robertscott | investorshub | 01/10/2023 7:56:15 PM |
Yes, nice to be able to take advantage | BlazingStocks | investorshub | 01/10/2023 6:58:12 PM |
Just the beginning. If they make it too | pumpnass | investorshub | 01/10/2023 6:27:30 PM |
Same here, buzz is picking up here! | budfoxfun | investorshub | 01/10/2023 5:09:13 PM |
Once we get through 0.165s, the $NBIO ASK | BlazingStocks | investorshub | 01/10/2023 4:25:35 PM |
Volume on the rise. $NBIO | Robertscott | investorshub | 01/10/2023 4:02:34 PM |
$NBIO trading nearly 20% of its 10-day average | BlazingStocks | investorshub | 01/10/2023 3:32:53 PM |
Excited to see how the market reacts to | BlazingStocks | investorshub | 01/10/2023 2:27:03 PM |
This is awesome News!! Closing enrollment for this | BlazingStocks | investorshub | 01/10/2023 2:25:33 PM |
Agree, way undervalued here! | budfoxfun | investorshub | 01/10/2023 2:23:33 PM |
This is a huge accomplishment! | pumpnass | investorshub | 01/10/2023 2:18:51 PM |
Closing enrollment for this final cohort of our | budfoxfun | investorshub | 01/10/2023 1:22:54 PM |
$NBIO wow huge news! Nascent Enrolls Final Patient | budfoxfun | investorshub | 01/10/2023 1:17:53 PM |
$NBIO News January 10, 2023 Nascent Enrolls Final Patient | BlazingStocks | investorshub | 01/10/2023 1:10:58 PM |
Nascent Enrolls Final Patient Cohort in Phase I | pumpnass | investorshub | 01/10/2023 1:05:07 PM |
$NBIO on my radar! | budfoxfun | investorshub | 01/10/2023 12:25:46 PM |
$NBIO trading just half of its 10-day average | BlazingStocks | investorshub | 12/20/2022 6:39:01 PM |
Yes, no questioning why $NBIO chose him to | BlazingStocks | investorshub | 12/20/2022 6:34:32 PM |
$HUGE addition to the $NBIO scientific advisory board... | BlazingStocks | investorshub | 12/20/2022 5:50:15 PM |
$NBIO .18's super thin on the ask! | budfoxfun | investorshub | 12/20/2022 4:38:04 PM |
News, Short Squeeze, Breakout and More Instantly...
NORTH PALM BEACH, FL / ACCESSWIRE / April 16, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, announces that it is embarking on a fresh manufacturin...
NORTH PALM BEACH, FL / ACCESSWIRE / March 19, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, and HypoSpray Pharma ("HypoSpray ® "), a clinical...
NORTH PALM BEACH, FL and NEW YORK, NY / ACCESSWIRE / February 6, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent"), a clinical-stage biotechnology company pioneering the development of monoclonal antibodies for the treatment of various cancers and viral infections, announc...